分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

Chiral nanoparticles drive enantiomer-specific osteogenic differentiation of stem cells and accelerate bone regeneration

Yuwen Wang, Zheng Zhong, Zeqing Li, Yuecong Guo, Christina Sin U. Ieong, Tao Yao, Boguang Yang, Ning Zhang, Songlin He, Zhilong Zhou, Jun Liu, Runxuan Cai, Yaling Wang, Chung Hang Jonathan Choi, Chuanbin Mao, Denghui Xie, Zhifeng Huang, Bo Liu, Maobin Xie, Chunying Chen, Zhong Alan Li

Journal:Science Advances

IF:13.9

DOI:10.1126/sciadv.aea3822

PMID:

Published:2026-06-10

research field:生物材料干细胞生物学再生医学组织工程纳米医学

Abstract

Precise control over stem cell differentiation is of crucial importance in regenerative medicine, such as stem cell–based bone repair. Chiral nanoparticles (NPs) exhibit enantiomer-dependent interactions with stem cells, providing a promising strategy for guiding cell behaviors. Here, we investigated the role of chiral NPs in modulating osteogenic differentiation of stem cells. L-CF-NPs, D-CF-NPs, and A-CF-NPs with controllable nanoscale chirality were synthesized to investigate the effect of enantioselectivity on stem cell fate. In vitro, L-CF-NPs resulted in the highest cellular uptake through clathrin-mediated, integrin-involved endocytosis. This led to the most pronounced up-regulation of osteogenic marker expression, mineralization (via MAPK/JNK/ERK), and angiogenic marker expression. In vivo, volumetric 3D-bioprinted scaffolds incorporating L-CF-NPs resulted in the fastest bone regeneration in a rat model of critical-size bone defects. This work establishes nanoscale chirality as a design parameter for biomaterials, offering a promising approach to regenerating bone and other tissues.

本文使用的Yeasen产品

购物车
客服
转染试用